The estimated Net Worth of Robert Edward Kelly is at least $2.91 Million dollars as of 3 May 2021. Robert Kelly owns over 2,053 units of Zoetis Inc stock worth over $1,576,917 and over the last 5 years Robert sold ZTS stock worth over $1,335,260.
Robert has made over 6 trades of the Zoetis Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Robert sold 2,053 units of ZTS stock worth $358,659 on 3 May 2021.
The largest trade Robert's ever made was exercising 2,909 units of Zoetis Inc stock on 14 February 2020 worth over $552,681. On average, Robert trades about 788 units every 26 days since 2020. As of 3 May 2021 Robert still owns at least 8,300 units of Zoetis Inc stock.
You can see the complete history of Robert Kelly stock trades at the bottom of the page.
Robert's mailing address filed with the SEC is C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY, NJ, 07054.
Over the last 12 years, insiders at Zoetis Inc have traded over $876,669,659 worth of Zoetis Inc stock and bought 1,602,140 units worth $77,083,975 . The most active insiders traders include Square Capital Management, ..., Frank A Damelio und Michael B Mccallister. On average, Zoetis Inc executives and independent directors trade stock every 14 days with the average trade being worth of $14,414,921. The most recent stock trade was executed by Soria Ester Banque on 31 July 2024, trading 895 units of ZTS stock currently worth $170,041.
Zoetis Inc. is an American drug company, the worlds largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the worlds largest drug maker, but with Pfizers spinoff of its 83% interest in the firm it is now a completely independent company.
Zoetis Inc executives and other stock owners filed with the SEC include: